Highlights The relative importance for serious side effects was the highest among all attributes. Mothers express more WTP for the quadrivalent vaccine compared to bivalent due to its protection against genital warts. Quadrivalent vaccination could be the most suitable candidate for implementation in the national immunization schedule.
Background & objectives: cardiovascular diseases are the main cause of mortality around the whole world. However, there is limited information on its economic costs in Iran. The aim of this study was to evaluate the economic costs of coronary heart disease in Iran in 2014. Methods: The diseases costs were calculated based on the incidence approach using a bottomup method and a community-oriented perspective. The drug cost information was obtained from angiographed patients (607 cases) in Shahid Modarres Hospital using simple random sampling method. Other information like disease incidence, distribution of patients, treatment patterns, length of stay and mortality rate was gathered from the literature, interview with patients, consultation with specialists, questionnaire, ministry of health and statistical center of Iran. Results: Coronary heart diseases impose a significant economic burden in the range of 4,715 and 4,908 billion dollars (210,037,860,000,000-201,778,425,000,000 rials) upon Iran economic system. The medical costs and the costs of lost productivity due to premature death were calculated at USD 3.572 billion (152,863,740,000,000 rials) and USD 933 million (39,927,735,000,000 rials) respectively. The major part of medical costs was related to angioplasty costs (47%) and the minor part was related to drug costs (1.15%). Conclusion: Coronary heart diseases impose a lot of financial costs to Iran healthcare system which cover more than 16% of whole healthcare financial costs. It is possible to streamline all consequential costs due to coronary heart disease by means of economic and effective use of resources and widespread self-care plan.
Background: Despite increasing global attention to the national human papillomavirus (HPV) immunization program, this program is controversial in Iran. Evidence indicate that HPV vaccination is not cost-effective in Iran. Using cost-effectiveness analysis for decision-making about public health interventions such as vaccination is debated, because its potential bene ts may not t this framework. Our objective was to evaluate economic effects of HPV vaccination by cost-bene t analysis (CBA). In this case, we used bivalent and quadrivalent in Iran in 2020.Methods: We performed a CBA from a societal perspective. We used two approaches of the vaccine's
Background: Socioeconomic status, as a major determinant of health, has a considerable impact on the cancer survival rate. The present study aimed to investigate the impact of socioeconomic factors on the 5-year survival rate for the most common cancer types in 56 countries. Methods: In this ecological study, 5-year survival data for gastric cancer, colon cancer, lung cancer, breast cancer, cervical cancer, ovarian cancer, prostate cancer, and leukemia during the period of 2005-2009 and socioeconomic factors including gross domestic product (GDP), life expectancy, literacy rate, urbanization and healthcare expenditure were extracted from the CONCORD-2 study and the World Bank database, respectively. multivariate regression analysis was used to estimate the model with the ordinary least-squares (OLS) method using Stata 14 software. Results: The GDP coefficient for breast cancer, cervical cancer, and leukemia was positive and significant. No correlation was identified between gastric, colon, lung, ovarian, and prostate cancer and GDP. Gastric, colon, breast, and prostate cancers had a positive and significant correlation with life expectancy. In contrast, no significant correlation was found between lung cancer, cervical cancer, ovarian cancer, leukemia and life expectancy. There was no correlation between cancer survival rate and literacy rate, or urbanization. There was only a positive correlation between prostate cancer and healthcare expenditure. Furthermore, there was no statistically significant relationship between gastric and ovarian cancers and socioeconomic variables. Finally, GDP and life expectancy had the most significant impact on cancer survival rates. Conclusion: Different countries can play a key role in increasing cancer survival rates by implementing policies to improve economic and social factors.
Background: Despite increasing global attention to the national human papillomavirus (HPV) immunization program, this program is controversial in Iran. Evidence indicate that HPV vaccination is not cost-effective in Iran. Using cost-effectiveness analysis for decision-making about public health interventions such as vaccination is debated, because its potential benefits may not fit this framework. Our objective was to evaluate economic effects of HPV vaccination by cost-benefit analysis (CBA). In this case, we used bivalent and quadrivalent in Iran in 2020. Methods: We performed a CBA from a societal perspective. We used two approaches of the vaccine's economic benefit: willingness to pay by discrete choice experiment; and cost of illness. Costs only included the vaccine cost. Results: The cost of two doses of bivalent and quadrivalent vaccines were US $ 29 and US $ 151, respectively (US $1 =IRR 42,000). The benefits of bivalent and quadrivalent vaccines were US $ -432, and US $ 380 per person using willingness to pay approach and they were US $ 7,375 and US $ 6,590 thorough cost-of-illness approach. The cost-benefit ratio (CBR) of bivalent and quadrivalent vaccines was -15.114 and 2.512 by willingness to pay approach, and it was 258.12 and 43.51, by cost of illness approach. Conclusions: This study confirms the benefit of both the national bivalent and quadrivalent vaccination program and provide reliable evidence for policy-makers when programming HPV vaccination.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.